A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2006
10/25/2006	CN1850816A Compound (2S)-5, 7.2', 6'-tetrahydroxy-6,8-diiso pentenyl-dihydro flavone extracting process and its use
10/25/2006	CN1850813A Degradeable furan sesterterpenes keratinous spongistatin, and its preparing method and use
10/25/2006	CN1850794A 3-amido substituted nenzoyl urea compound, and its antitumor action
10/25/2006	CN1850762A Cyclic alcohol derivative keratinous sponge alcohol, and its preparing method and use
10/25/2006	CN1850279A PcrDNA vaccine, and its preparing method and use
10/25/2006	CN1850277A Gamma-polyglutaic acid-CDDP complex, and its preparing method and use
10/25/2006	CN1850276A Taxol polymer bond drug lyophilized powder injection and its preparing method
10/25/2006	CN1850263A Chinese medicine composition for treating malignancy above diaphragm
10/25/2006	CN1850252A Method for treating throat cancer
10/25/2006	CN1850236A Method for preparing medicine for treating malignancy disease and use thereof
10/25/2006	CN1850228A Chinese medicine composition for malignancy below diaphragm and preparing method therefor
10/25/2006	CN1850219A Shenling Chinese medicine preparation for strengthening body resistance
10/25/2006	CN1850183A Chemical therapy medicine for treating rectum cancer
10/25/2006	CN1850135A Duck-gallbladder-oil enteric coatal soft capsule preparation, its preparing method and use
10/25/2006	CN1850128A Pine pollen composition with beauty nourish function to face, intensifying immunity of body
10/25/2006	CN1850107A Fatty cream composition for maligant splanchnocoele hydrops and its preparing method
10/25/2006	CN1850104A Compound lentinan preparation and its preparing method
10/25/2006	CN1850103A Compound lentinan preparation for antitumour and its preparing method
10/25/2006	CN1850102A Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method
10/25/2006	CN1850099A Protopanaxadiol lyophilized agent and its preparing method
10/25/2006	CN1850098A Protopanaxadiol liposome and its preparing method
10/25/2006	CN1850096A Aclarubicin venous emulsion and its preparing method
10/25/2006	CN1850095A Use of chonglou saponin compound
10/25/2006	CN1850082A Desoxyribose nucleic acid dual intercalating agent using methyl iso thiourea cation as linker
10/25/2006	CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor
10/25/2006	CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006	CN1850066A Carboplatin venous emulsion and its preparing method
10/25/2006	CN1850061A Use of triethylene-tetramine as antitumour auxiliary drug
10/25/2006	CN1850056A Taxotere lyophilized powder and its preparing method
10/25/2006	CN1850053A Chemotherapeutic emulsion for treating rectum cancer
10/25/2006	CN1850052A Loaded vascular inhibitor and cellulutoxic drug slow-release injection
10/25/2006	CN1850051A Loaded vascular inhibitor and cellulotoxic drug anticancer slow-release injection
10/25/2006	CN1850050A Compound anticancer slow-release injection containing vascular inhibitor
10/25/2006	CN1850049A Loaded vascular inhibitor and cellulotoxic drug anticancer slow-release injection
10/25/2006	CN1850048A Anticancer slow-release injection containing vascular inhibitor
10/25/2006	CN1850042A Anti-cancer slow-release preparation containing platinum medicines and its synergist
10/25/2006	CN1850041A Anticancer medicine slow-release preparation containing platinum compound and its synergist
10/25/2006	CN1850038A Slow-release injecta containing blood vessel inhibitor and synergist thereof
10/25/2006	CN1850037A Compound anti-cancer slow-release injected containing blood vessel inhibitor
10/25/2006	CN1850033A Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor
10/25/2006	CN1281753C Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses
10/25/2006	CN1281752C Carcinoma of esophagus related gene-2 and use of coding protein thereof
10/25/2006	CN1281748C Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
10/25/2006	CN1281625C WT1 modified peptide
10/25/2006	CN1281618C Novel depsipeptide compound
10/25/2006	CN1281616C Compound extracted from hull and stem of yellow horn, extracting method and application
10/25/2006	CN1281613C Chinese medicine gelsmium elegans total alkaloid for anticancer and analgesia, and medicinal composition containing it and preparing method thereof
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281279C Small interference ribonucleic acid molecule for epidermal growth facor gene and its use
10/25/2006	CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/25/2006	CN1281263C Medicine for treating mammary cancer recurrence and metastasis and the preparation thereof
10/25/2006	CN1281262C Chinese medicine for gynaecological tumor and preparation method
10/25/2006	CN1281258C Cosmetic use of hop and ornithine
10/25/2006	CN1281218C Preparation method of clam meat extract
10/25/2006	CN1281210C Application of Schisandrin-B in preparing medicine for treating tumor
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126001 Antiproliferative agents; antitumor agents
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125852 Geranyl compounds
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125554 Engineered superantigen for human therapy
10/24/2006	US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker
10/24/2006	CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
10/24/2006	CA2264929C Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
10/24/2006	CA2252717C Colchicine-skeleton compounds, their use as medicaments and compositions containing them
10/19/2006	WO2006110814A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/19/2006	WO2006110594A2 Sema4d in cancer diagnosis, detection and treatment
10/19/2006	WO2006110483A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	WO2006110476A2 Cytotoxic compounds and conjugates comprising duocarmycins with cleavable substrates
10/19/2006	WO2006110175A2 Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
10/19/2006	WO2006110119A1 Antineoplastic preparation
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109762A1 Novel process for producing ramosetron or its salt
10/19/2006	WO2006109680A1 Use of 3,5-diphenylpyrazole analogue as anti-tumor agent
10/19/2006	WO2006109675A1 Antitumor agent and novel dnase
10/19/2006	WO2006109635A1 Intestinal absorptive anti-tumor agent
10/19/2006	WO2006109188A2 Composition for treating cancer adapted for intra-tumoral asministration and uses thereof
10/19/2006	WO2006109092A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	WO2006109091A2 Sensitisation of cancer cells to dna replication inhibitors

1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 2211